Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$0.13 - $0.44 $16,636 - $56,307
-127,971 Reduced 42.41%
173,774 $61,000
Q4 2022

Feb 14, 2023

SELL
$0.13 - $0.2 $19,225 - $29,578
-147,890 Reduced 32.89%
301,745 $44,000
Q3 2022

Nov 14, 2022

SELL
$0.17 - $0.3 $34,275 - $60,486
-201,623 Reduced 30.96%
449,635 $77,000
Q2 2022

Aug 15, 2022

BUY
$0.24 - $0.91 $85,511 - $324,231
356,298 Added 120.8%
651,258 $157,000
Q1 2022

May 16, 2022

BUY
$1.02 - $2.46 $50,459 - $121,696
49,470 Added 20.15%
294,960 $307,000
Q4 2021

Feb 14, 2022

BUY
$2.06 - $4.05 $95,130 - $187,029
46,180 Added 23.17%
245,490 $523,000
Q3 2021

Nov 15, 2021

BUY
$3.18 - $5.08 $3,714 - $5,933
1,168 Added 0.59%
199,310 $672,000
Q2 2021

Aug 16, 2021

BUY
$3.83 - $6.31 $758,883 - $1.25 Million
198,142 New
198,142 $797,000
Q1 2021

May 17, 2021

SELL
$4.25 - $12.01 $140,815 - $397,927
-33,133 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$3.21 - $5.68 $106,356 - $188,195
33,133 New
33,133 $140,000
Q4 2019

Feb 14, 2020

SELL
$3.6 - $7.27 $179,420 - $362,329
-49,839 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$5.64 - $12.82 $198,951 - $452,225
35,275 Added 242.21%
49,839 $281,000
Q2 2019

Aug 14, 2019

BUY
$12.24 - $17.4 $178,263 - $253,413
14,564 New
14,564 $182,000
Q1 2019

May 14, 2019

SELL
$10.38 - $18.97 $287,173 - $524,824
-27,666 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$9.33 - $14.99 $258,123 - $414,713
27,666 New
27,666 $287,000
Q3 2018

Nov 14, 2018

SELL
$15.19 - $18.54 $473,882 - $578,392
-31,197 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$13.37 - $21.46 $417,103 - $669,487
31,197 New
31,197 $582,000
Q4 2017

Feb 14, 2018

SELL
$17.13 - $31.48 $205,474 - $377,602
-11,995 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$11.82 - $28.31 $141,780 - $339,578
11,995
11,995 $294,000

About Calyxt, Inc.


  • Ticker CLXT
  • Exchange NASDAQ
  • Sector Consumer Defensive
  • Industry Packaged Foods
  • Shares Outstandng 46,792,100
  • Market Cap $913M
  • Description
  • Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a higher fiber content. It has a commercialization agreement with S&W Seed Company for the excl...
More about CLXT
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.